Birch Pollen Allergy- Development by Companies, Healthcare latest pipeline Guide 2019

Posted on 2019-09-30 by Mark Hub in Pharmaceuticals // 0 Comments

Albany, US, 2019-Sep-30 — /EPR Network/ —Market Research Hub (MRH) has actively included a new research study titled “Birch Pollen Allergy-Pipeline Review, H2 2019” to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period until 2019. In addition, a deep analysis of the competitive landscape, including prime market players is also enclosed in this report.

Get Sample Copy@ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2519465

Birch Pollen Allergy – Pipeline Review, H2 2019

Summary

Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Birch Pollen Allergy – Pipeline Review, H2 2019, provides an overview of the Birch Pollen Allergy (Immunology) pipeline landscape.

Birch pollen allergy is a reaction which occurs soon after exposure to pollen of birch trees. Signs and symptoms include skin reactions, such as hives, redness or swelling, itching or tingling in or around the mouth and throat, digestive problems, such as diarrhea, stomach cramps, nausea or vomiting, tightening of the throat, shortness of breath or wheezing and runny nose. Predisposing factors include age, family history and other allergies. Treatment includes drugs belonging to class of antihistamines.

Report Highlights

Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Birch Pollen Allergy – Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Birch Pollen Allergy (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Birch Pollen Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Birch Pollen Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase I, Preclinical and Discovery stages are 1, 1, 3, 3 and 2 respectively.

Birch Pollen Allergy (Immunology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Birch Pollen Allergy (Immunology).
– The pipeline guide reviews pipeline therapeutics for Birch Pollen Allergy (Immunology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Birch Pollen Allergy (Immunology) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Birch Pollen Allergy (Immunology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Birch Pollen Allergy (Immunology)

Request TOC of the Report @ https://www.marketresearchhub.com/report/birch-pollen-allergy-pipeline-review-h2-2019-report.html

Table of Contents

List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Birch Pollen Allergy – Overview
Birch Pollen Allergy – Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Birch Pollen Allergy – Therapeutics Assessment
Assessment by Target
Assessment by Route of Administration
Assessment by Molecule Type
Birch Pollen Allergy – Companies Involved in Therapeutics Development
Anergis SA
Biomay AG
Desentum Oy
HAL Allergy BV
Laboratorios LETI SL
Regeneron Pharmaceuticals Inc
S-TARget therapeutics GmbH
Birch Pollen Allergy – Drug Profiles
Allergen for Allergic Rhinitis, Allergic Rhino-Conjunctivitis and Birch Pollen Allergy – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
birch pollen allergen extract – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BM-31 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PL-102 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
REGN-5713 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
REGN-5714 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
REGN-5715 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SG-300 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Vaccine for Birch Pollen Allergy – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Vaccines For Birch Pollen Allergy – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Birch Pollen Allergy – Dormant Projects
Birch Pollen Allergy – Discontinued Products
Birch Pollen Allergy – Product Development Milestones
Featured News & Press Releases

Continued………..#@
Enquire about This Report @ https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=2519465

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like Pharmaceuticals market research and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick